{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:08:20Z","timestamp":1783652900153,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.pnpbp.2006.01.018","type":"journal-article","created":{"date-parts":[[2006,3,8]],"date-time":"2006-03-08T12:21:46Z","timestamp":1141820506000},"page":"758-760","source":"Crossref","is-referenced-by-count":12,"title":["Hypersalivation induced by olanzapine with fluvoxamine"],"prefix":"10.1016","volume":"30","author":[{"given":"Takafumi","family":"Hori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Makabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Asada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2006.01.018_bib1","series-title":"Diagnostic and statistical manual of mental disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.pnpbp.2006.01.018_bib2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/00004714-200112000-00012","article-title":"Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: a randomized, double-blind, placebo-controlled, cross-over study","volume":"21","author":"Bai","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.01.018_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00004714-200006000-00004","article-title":"Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine","volume":"20","author":"Chengappa","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.01.018_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s002130100713","article-title":"Interaction of olanzapine with fluvoxamine","volume":"155","author":"De Jong","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2006.01.018_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4088\/JCP.v63n0213g","article-title":"Olanzapine for the treatment of monosymptomatic hypochondriacal psychosis","volume":"63","author":"Fawcett","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.01.018_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00004714-199202000-00026","article-title":"Clonidine treatment of clozapine-induced hypersalivation","volume":"12","author":"Grabowski","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.01.018_bib7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/00004714-200210000-00010","article-title":"Fluvoxamine augmentation of olanzapine in chronic schizophrenia: pharmacokinetic interactions and clinical effects","volume":"22","author":"Hiemke","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.01.018_bib8","first-page":"20","article-title":"Refractory obsessive\u2013compulsive disorder: state-of-the-art treatment","volume":"63","author":"Hollander","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.01.018_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/10401230309085687","article-title":"Adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia","volume":"15","author":"Kelly","year":"2003","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.01.018_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1192\/S0007125000298978","article-title":"Monosymptomatic hypochondriacal psychosis","volume":"153","author":"Munro","year":"1988","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.01.018_bib12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1176\/ajp.155.7.993a","article-title":"Hypersalivation coincident with olanzapine treatment","volume":"155","author":"Perkins","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.01.018_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2004-815523","article-title":"Reduction of clozapine-induced hypersalivation by pirenzepine is safe","volume":"37","author":"Schneider","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2006.01.018_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0924-977X(96)00031-4","article-title":"The antinociceptive effect of fluvoxamine","volume":"6","author":"Schreiber","year":"1996","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.01.018_bib15","series-title":"Essential psychopharmacology","first-page":"401","article-title":"Antipsychotic agents","author":"Stahl","year":"2000"},{"key":"10.1016\/j.pnpbp.2006.01.018_bib16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1177\/0091270004266621","article-title":"The differential effects of steady-state fluvoxamine on the pharmacokinetics of olanzapine and clozapine in healthy volunteers","volume":"44","author":"Wang","year":"2004","journal-title":"J Clin Pharmacol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606000443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606000443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T07:01:34Z","timestamp":1555484494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584606000443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0278584606000443"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2006.01.018","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}